Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...

Tweaking the spacing between binding domains on the ECM surrounding cancer cells can boost their killing via ultrasound ...

Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

In a new study, Cold Spring Harbor Laboratory Professor Hiro Furukawa and postdoc Hyunook Kang prove the existence of a mysterious brain receptor known as GluN1-2B-2D. They also show several ways the ...

People you wouldn’t normally associate with drug use are self-treating by microdosing with psychedelics. Doctors need to be ...

tividenofusp alfa is designed to have low binding affinity to the target receptor. This property enables the drug to latch on to transferrin to get across the blood-brain barrier but then be ...

The View/ABC Whoopi Goldberg sounded off on a fake AI ad that uses her image to sell a weight-loss drug, saying, “I had nothing to do it with.” “I’m giving everybody a heads up.

Abstract: Predicting drug-target binding affinity is critical for drug discovery, as it helps identify promising drug candidates and predict their effectiveness. Recent advancements in deep learning ...

Epidemiologic studies have shown that prolactin levels in the high-normal range, as well as medications that ... via a competitive mechanism for receptor binding. In this review, we discuss ...

It can also range from mild to severe. Substance use disorder, formerly known as “drug abuse,” develops when substance use interferes with the ability to function day to day. Substance use ...